MUADP identifies animal drug needs for minor species, and minor uses in major species. Minor species include lamb, sheep, goats, salmon, cod, catfish, and other popular seafood animals. MUADP also generates and disseminates data for safe and effective therapeutic applications and facilitates FDA approval for drugs identified as a priority for a minor species or a minor use. MUADP makes pharmaceutical products available to producers, which in turn allows producers to remain competitive in the marketplace.

 
Without the MUADP American producers of minor species would not have safe and effective products to keep their livestock healthy. Agricultural production of minor species is critically important to numerous regional economies in the U.S. This diverse aggregation of minor species represents approximately $4.4 billion in food and fiber farm gate revenues annually. Processing, use, and export of minor species food and fiber products represent an additional $34 billion economic impact tothe U.S.